The rising
geriatric population base, increasing global incidence of various STIs,
rise in sedentary lifestyle adoption levels, and rising awareness &
patient education are the driving forces for the STD diagnostics market
growth over the forecast period.
Increasing number of people having multiple partners and low levels
of infection awareness levels are the major drivers fueling industrial
growth. Increasing demand for rapid and accurate diagnostic tests and
presence of favorable government initiatives for STD testing in
developing countries such as Brazil, India, and China are further
estimated to boost market growth.
Browse Detail Report With TOC @
Further key findings from the study suggest:
Chlamydia testing accounted for over 34% of the market in 2014.
Chlamydia testing for sexually active women aged below 25 years is
strictly recommended by the U.S Preventive Services Task Force (PSTF).
Syphilis testing is estimated to witness lucrative growth over the
forecast period. It is anticipated to grow at a CAGR of 10% owing to
increasing prevalence of syphilis infection globally.
On the basis of test location, laboratory testing held the largest
market share of over 63% in 2014 owing to the availability of cost
effective diagnostic tests used for multiple STIs at a single location
such as public health labs. Point of care on the other hand is
anticipated to be the fastest growing segment over the forecast period
owing to the owing to the introduction of CLIA waived tests.
Laboratory testing devices dominated the market in 2014 with revenue
generation of over 67.0 billion. Immunochromatographic assays were most
preferred devices for STD diagnosis in laboratory with revenue share of
over 26%. Increasing technological advancements are estimated to enhance
usage rates of thermal cyclers over the forecast period.
Portable/bench top or rapid diagnostic kits are estimated to gain
demand over the forecast period owing to features such as
user-friendliness, increasing awareness pertaining to self testing, and
fast results.
North America held the largest share of the STD diagnostics market
with revenue generation of over 32 billion in 2014. Introduction of
technologically advanced diagnostics techniques such as
immunochromatographic device by Chembio Diagnostics Systems Inc. is the
major factor attributing for its largest market share.
Request A Sample copy of This Report @ http://www.hexareports.com/sample/98289
Asia Pacific region is estimated to witness significant growth over
the forecast period owing to the presence of high amount of target
population, rising awareness levels for STIs, and increasing government
initiatives and rise in disposable income expenditure levels. Asia
Pacific is expected to show double digit CAGR growth over the forecast
period.
Major companies of the STD diagnostics industry include Roche
Holdings AG, Abbott Laboratories, Becton Dickinson and Company, Hologic
Inc., Danaher Corporation, Affymetrix, BioMerieux, Cepheid Inc., Alere
Inc., DiaSorin, and Orasure
Licensing and partnership deal making activities in the molecular
diagnostics sector are growing significantly in terms of value. New
entrants such as life science research groups, financial investors,
clinical laboratories, and medical technology players drive up the
values.
About Us:
Hexa Reports is a market research and consulting organization, offering
industry reports, custom research and consulting services to a host of
key industries across the globe. We offer comprehensive business
intelligence in the form of industry reports which help our clients
obtain clarity about their business environment and enable them to
undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: sales@hexareports.com
Website: http://www.hexareports.com/
Visit our Blog: http://hexareports.blogspot.com/
No comments:
Post a Comment